Body composition, glucose metabolism markers and serum androgens - association in women with polycystic ovary syndrome

被引:0
作者
Kozakowski, Jaroslaw [1 ]
Zgliczynski, Wojciech [1 ]
机构
[1] Bielanski Hosp, Med Ctr Postgrad Educ, Dept Endocrinol, PL-01809 Warsaw, Poland
关键词
polycystic ovary syndrome; body composition; obesity; hyperandrogenism; insulin resistance; INSULIN-RESISTANCE; ENDOTHELIAL DYSFUNCTION; FAT DISTRIBUTION; SYNDROME PCOS; OBESE; INFLAMMATION; ENDOCRINE; DIAGNOSIS; NONOBESE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: To evaluate the association between abdominal and gynoid fat, glucose and lipid metabolism markers, and serum androgens in women with polycystic ovary syndrome (PCOS). Material and methods: Anthropometric measurements were performed in 40 women with PCOS aged 19-49 years with body mass index (BMI) 18.7-53.8 kg/m(2). Fasting serum glucose, lipids, insulin, leptin, LH, FSH, oestradiol, androgens, SHGB and TSH were estimated. Body composition was measured by DEXA scan. Results: Four women (10%) were overweight, and 23 (57.5%) were obese. All subjects were hyperandrogenic (in 33 serum androgen levels were increased), and 16 of them were insulin resistant. All of the obese subjects had the abdominal type of obesity. Body weight, BMI, fat mass, fat mass of the trunk, abdominal and gynoidal fat mass correlated with serum triglyceride, glucose and insulin levels, and with HOMA index and blood pressure. Free androgen index (FAI) correlated with body weight (r = 0.43, p < 0.01), and BMI (r = 0.46, p < 0.05). Conclusions: Using the DEXA method, we demonstrated abdominal type of obesity in all our obese subjects. There were positive significant correlations between fatness, lipids and glucose metabolism indices and blood pressure. Direct positive correlations between free androgen index, body weight and BMI were found. (Endokrynol Pol 2013; 64 (2): 94-100)
引用
收藏
页码:94 / 100
页数:7
相关论文
共 31 条
[1]   Polycystic ovary syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women [J].
Carmina, E ;
Lobo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) :1897-1899
[2]   Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance [J].
Carmina, Enrico ;
Bucchieri, Salvo ;
Esposito, Antonella ;
Del Puente, Antonio ;
Mansueto, Pasquale ;
Orio, Francesco ;
Di Fede, Gaetana ;
Rini, GiovamBattista .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (07) :2500-2505
[3]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[4]   Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment [J].
DeUgarte, CM ;
Bartolucci, AA ;
Azziz, R .
FERTILITY AND STERILITY, 2005, 83 (05) :1454-1460
[5]   Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin [J].
Diamanti-Kandarakis, Evanthia ;
Paterakis, Thomas ;
Alexandraki, Krystallenia ;
Piperi, Christina ;
Aessopos, Athanasios ;
Katsikis, Ilias ;
Katsilambros, Nikolaos ;
Kreatsas, George ;
Panidis, Dimitrios .
HUMAN REPRODUCTION, 2006, 21 (06) :1426-1431
[6]   Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis [J].
Dunaif, A .
ENDOCRINE REVIEWS, 1997, 18 (06) :774-800
[7]   Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome [J].
Faloia, E ;
Canibus, P ;
Gatti, C ;
Frezza, F ;
Santangelo, M ;
Garrapa, GGM ;
Boscaro, M .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2004, 27 (05) :424-429
[8]  
Foltyn W, 2011, ENDOKRYNOL POL, V62, P243
[9]   Obesity and the polycystic ovary syndrome [J].
Gambineri, A ;
Pelusi, C ;
Vicennati, V ;
Pagotto, U ;
Pasquali, R .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (07) :883-896
[10]   Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome [J].
Godoy-Matos, Amelio F. ;
Vaisman, Fernanda ;
Pedrosa, Aline P. ;
Farias, Maria L. F. ;
Mendonca, Laura Maria C. ;
Pinheiro, Maria Fernanda M. C. .
GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (12) :793-798